| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | US7176189 Methods for regeneration of a mammalian lens |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7175984 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/08/2007 | WO2007015003A2 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 02/08/2007 | WO2007015002A2 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 02/08/2007 | WO2006129318A3 Benzofuran derivatives with therapeutic activities |
| 02/08/2007 | WO2005103054A3 Bridged piperazine and piperidine derivatives as ccri antagonists |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032507 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug. |
| 02/08/2007 | US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 02/08/2007 | US20070032417 Peptides and therapeutic uses thereof |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031887 Aqueous-based pharmaceutical composition |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031447 Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031441 Immunotherapy based on dendritic cells |
| 02/08/2007 | US20070031433 Tumor antigen |
| 02/08/2007 | US20070031432 Tumor antigen |
| 02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 02/08/2007 | US20070031415 Regulation of interaction between rapl and rap1 |
| 02/08/2007 | US20070031377 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 02/08/2007 | US20070031368 Chemokine conjugates |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
| 02/07/2007 | EP1749534A2 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1748775A1 Pharmaceutical products for treating neoplastic disease and inflammation |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1292333B1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1231920B1 Use of epinastin for the treatment of allergic rhinitis/conjunctivitis |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP1126860B1 Immunomodulatory factors for immunosuppressant and antiallergic treatment |
| 02/07/2007 | EP0870022B1 Immunostimulatory composition and method |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | CN1909925A Immunologic adjuvant |
| 02/07/2007 | CN1909918A T cell immunoreaction inhibitor |
| 02/07/2007 | CN1909881A Process for producing maca extract |
| 02/07/2007 | CN1908182A Preparation for amylovorin of bacillus and application thereof |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1908012A Cell surface molecule mediating cell adhesion and signal transmission |
| 02/07/2007 | CN1907967A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 02/07/2007 | CN1907433A Process for extracting physiologically active substance from highland barley tender leaf |
| 02/07/2007 | CN1907419A Decoction preparation for treating xuezaoshengfeng type skin eczema and its preparation process |
| 02/07/2007 | CN1907392A Decoction preparation for treating acute pruritus type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907378A Decoction preparation for treating QIXUELIANGXU type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907368A Decoction preparation for treating heat-toxin type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907367A Decoction preparation for treating obstinate chronic urticaria and its preparation process |
| 02/07/2007 | CN1907366A Decoction preparation for treating damp-heat type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907365A Decoction preparation for treating wind-heat type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907364A Decoction preparation for treating wind-cold type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907363A Decoction preparation for treating blood stasis type chronic urticaria and its preparation process |
| 02/07/2007 | CN1907351A Decoction preparation for treating acute urticaria and its preparation process |
| 02/07/2007 | CN1907350A Composition, extract thereof and its pharmaceutical use |
| 02/07/2007 | CN1907332A Decoction preparation for treating cold type urticaria and its preparation process |
| 02/07/2007 | CN1907328A Kuh-seng gel formulation and its preparing process |
| 02/07/2007 | CN1907301A Health care oral liquid of phellinus igniarius and its preparing method |
| 02/07/2007 | CN1907299A Oral liquor containing biological protein and its preparing method |
| 02/07/2007 | CN1907289A Prophylactic and therapeutic treatment of infectious and other diseases with mono and disaccharide-based compounds |
| 02/07/2007 | CN1298856C Technique for improving activity of Job's-tears seed |
| 02/07/2007 | CN1298848C Analog of haemophilus Hin47 with reduced protease activity |
| 02/07/2007 | CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application |
| 02/07/2007 | CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298703C Cyanopyrolidine derivatives |
| 02/07/2007 | CN1298387C Vaccine composition and stabilisation method |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173117 Codon optimised recombinant Dermaphagoides allergens |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7172867 Methods of testing for allergic diseases, and therapeutic agents for treating same |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172768 Storage stable powder compositions of interleukin-4 receptor |
| 02/06/2007 | US7172759 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 02/06/2007 | US7172756 Methods of promoting tolerogenic immune responses and compositions therefor |